{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:51:30Z","timestamp":1791352290568,"version":"4.3.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.jaad.2007.09.024","type":"journal-article","created":{"date-parts":[[2007,11,14]],"date-time":"2007-11-14T17:04:10Z","timestamp":1195059850000},"page":"60-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["Efficacy and tolerance of acne treatment using both spironolactone and a combined contraceptive containing drospirenone"],"prefix":"10.1016","volume":"58","author":[{"given":"Aleksandar","family":"Krunic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Ciurea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Scheman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2007.09.024_bib1","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2165\/00128071-200203080-00007","article-title":"Acne: effect of hormones on pathogenesis and management","volume":"3","author":"Shaw","year":"2002","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2007.09.024_bib2","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0190-9622(97)70112-9","article-title":"Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris","volume":"37","author":"Lucky","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2007.09.024_bib3","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0029-7844(97)00059-8","article-title":"Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial","volume":"89","author":"Redmond","year":"1997","journal-title":"Obstet Gynecol"},{"issue":"Suppl 4","key":"10.1016\/j.jaad.2007.09.024_bib4","first-page":"2","article-title":"The effect of 2 combined oral contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea","volume":"69","author":"van Vloten","year":"2002","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2007.09.024_bib5","first-page":"157","article-title":"The effectiveness of oral cyproterone acetate in combination with ethinylestradiol in acne tarda of the facial type","volume":"60","author":"Gollnick","year":"1999","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.jaad.2007.09.024_bib6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000057878","article-title":"Have oral contraceptives reduced the prevalence of acne? A population-based study of acne vulgaris, tobacco smoking and oral contraceptives","volume":"204","author":"Jemec","year":"2002","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2007.09.024_bib7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/09513590009167685","article-title":"Inhibition of skin 5 alpha-reductase by oral contraceptive progestins in vitro","volume":"14","author":"Rabe","year":"2000","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.jaad.2007.09.024_bib8","first-page":"123","article-title":"Superiority of a combined contraceptive containing drospirenone to a triphasic preparation containing norgestimate in acne treatment","volume":"74","author":"Thorneycroft","year":"2004","journal-title":"Cutis"},{"issue":"Suppl 3","key":"10.1016\/j.jaad.2007.09.024_bib9","first-page":"49","article-title":"Drospirenone: a new cardiovascular-active progestin with antialdosterone and antiandrogenic properties","volume":"6","author":"R\u00fcbig","year":"2003","journal-title":"Climacteric"},{"key":"10.1016\/j.jaad.2007.09.024_bib10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2133.1984.tb04045.x","article-title":"Oral spironolactone improves acne vulgaris and reduces sebum excretion","volume":"111","author":"Goodfellow","year":"1984","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2007.09.024_bib11","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1365-2133.1985.tb02305.x","article-title":"Oral spironolactone therapy for female patients with acne, hirsutism or androgenic alopecia","volume":"112","author":"Burke","year":"1985","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2007.09.024_bib12","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2133.1986.tb05722.x","article-title":"Oral spironolactone: an effective treatment for acne vulgaris in women","volume":"115","author":"Muhlemann","year":"1986","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2007.09.024_bib13","first-page":"84","article-title":"Spironolactone and cimetidine in treatment of acne","volume":"68","author":"Hatwal","year":"1988","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"10.1016\/j.jaad.2007.09.024_bib14","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1365-2133.1988.tb02571.x","article-title":"Tolerance of spironolactone","volume":"118","author":"Hughes","year":"1988","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2007.09.024_bib15","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1067\/mjd.2000.105557","article-title":"Low-dose adjunctive spironolactone in the treatment of acne in women: a retrospective analysis of 85 consecutively treated patients","volume":"43","author":"Shaw","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2007.09.024_bib16","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1046\/j.1365-2265.2003.16911.x","article-title":"Different effectiveness of cyproterone acetate doses in treatment of acne","volume":"58","author":"De Leo","year":"2003","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.jaad.2007.09.024_bib17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0010-7824(00)00133-5","article-title":"Drospirenone: pharmacology and pharmacokinetics of a unique progestogen","volume":"62","author":"Krattenmacher","year":"2000","journal-title":"Contraception"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962207014521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962207014521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:08:35Z","timestamp":1759270115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962207014521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0190962207014521"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2007.09.024","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and tolerance of acne treatment using both spironolactone and a combined contraceptive containing drospirenone","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2007.09.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}